Buffalo-based biotechnology firm ZeptoMetrix Corp., a prominent company in the fight against infectious diseases, has been acquired by a Chicago-based private equity firm GTCR. GTCR bought ...

Congratulations to ZeptoMetrix, one of the winners of our ninth annual awards celebrating the best in manufacturing. Acquisition will pave way for more ZeptoMetrix growth in Buffalo Buffalo ...

IDbyDNA will use the Explify ® metagenomics technology platform to analyze such materials provided by ZeptoMetrix to ensure the accurate identification, molecular typing, and biological purity of ...

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic ...

ZeptoMetrix®, an Antylia Scientific™ company, adds one more addition to its expansive line of infectious disease quality controls and is now available for pre-order. "As a partner to our ...

ZeptoMetrix will soon occupy two-thirds of the former SmartPill building owned by Buffalo Niagara Medical Campus Inc. ZeptoMetrix is adding to its space on the Buffalo Niagara Medical Campus to ...

ZeptoMetrix™ newly inactivated and non-infectious NATtrol™ SARS-CoV-2 Recombinant (0831402) is available for laboratory quality control and test validation. This non-infectious quality control ...

BUFFALO, N.Y., May 5, 2020 /PRNewswire-PRWeb/ -- Continuing in its efforts to rapidly respond to today's COVID-19 pandemic, ZeptoMetrix Corporation (ZMC) announced today the development and ...

BUFFALO, NY / ACCESSWIRE / October 3, 2023 / ZeptoMetrix® is pleased to announce it has been awarded an IVDR Quality Management System certificate from British Standards Institution BSI, NB 2797, one ...

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a ...